Facilitated angioplasty: Paradise lost

Lancet

Volumn 367, Issue 9510, 2006, Pages 543-546

  Stone, Gregg W ^a,c   Gersh, Bernard J ^b  

^a NewYork Presbyterian Hospital   (United States)

^b MAYO CLINIC   (United States)

^c Guidant and Boston Scientific Corporations   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN;

ACUTE HEART INFARCTION; ANGIOPLASTY; BLOOD CLOT LYSIS; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART INFARCTION; HEART PERFUSION; HEART REINFARCTION; HUMAN; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

EID: 32644486858     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68149-X     Document Type: Note

References (35)

1. MJ Davies, AC Thomas Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina Br Heart J 53 1985 363 373
2. MA DeWood, J Spores, R Notske Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction N Engl J Med 303 1980 897 902
3. EC Keeley, JA Boura, CL Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
4. A Schömig, A Kastrati, J Dirschinger Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction N Engl J Med 334 1996 1084 1089
5. R Moreno, J Lopez-Sendon, E Garcia Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction J Am Coll Cardiol 39 2002 598 603
6. KA Reimer, RB Jennings The "wavefront phenomenon" of myocardial ischemic cell death II: transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow Lab Invest 40 1979 633 644
7. BK Nallamothu, ER Bates Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction Am J Cardiol 92 2003 824 826
8. BR Brodie, C Hansen, TD Stuckey Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms J Am Coll Cardiol 47 2006 289 295
9. G De Luca, H Suryapranata, JP Ottervanger, EM Antman Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction Circulation 109 2004 1223 1225
10. WJ Rogers, DS Baim, JM Gore for the TIMI II-A Investigators Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator Circulation 81 1990 1457 1476
11. ML Simoons, Arnold AER, A Betriu for the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator (rTPA) Thrombolysis with tissue plasminogen activator in acute myocardial infarction Lancet 1 1988 197 203
12. SWIFT Trial Study Group SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction BMJ 302 1991 555 560
13. GI Barbash, A Roth, H Hod Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction Am J Cardiol 66 1990 538 545
14. GW Stone, CL Grines, DA Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
15. MR Le May, GA Wells, M Labinaz Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study) J Am Coll Cardiol 46 2005 417 424
16. F Fernandez-Aviles, JJ Alonso, A Castro-Beiras on behalf of the GRACIA (Grupo de Análisis de la Cardiopatía Isquémica Aguda) Group Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial Lancet 364 2004 1045 1053
17. B Scheller, B Hennen, B Hammer for the SIAM III Study Group Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction J Am Coll Cardiol 42 2003 634 641
18. AH Gershlick, A Stephens-Lloyd, S Hughes Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction N Engl J Med 353 2005 2758 2768
19. GW Stone, D Cox, E Garcia Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction Circulation 104 2001 636 641
20. G De Luca, N Ernst, F Zijlstra Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty J Am Coll Cardiol 43 2004 1363 1367
21. EC Keeley, JA Boura, CL Grines Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials Lancet 367 2006 579 588
22. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial Lancet 367 2006 569 578
23. BJ Gersh, GW Stone, HD White, DR Holmes Jr Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 293 2005 979 986
24. CP Cannon, CM Gibson, CT Lambrew Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
25. R Zahn, A Vogt, U Zeymer In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome - results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte Heart 91 2005 1041 1046
26. RL McNamara, J Herrin, EH Bradley Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002 J Am Coll Cardiol 47 2006 45 51
27. The TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) Trial: phase 1 findings N Engl J Med 312 1985 932 936
28. MT Rothman Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options Nat Clin Pract Cardiovasc Med 2 2005 465 474
29. BF Waller, DA Rothbaum, CA Pinkerton Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy J Am Coll Cardiol 9 1987 785 801
30. Y Ohnishi, MC Butterfield, JE Saffitz Deleterious effects of a systemic lytic state on reperfused myocardium: minimization of reperfusion injury and enhanced recovery of myocardial function by direct angioplasty Circulation 92 1995 500 510
31. K Kawano, I Aoki, N Aoki Human platelet activation by thrombolytic agents: effects of tissue-type plasminogen activator and urokinase on platelet surface P-selectin expression Am Heart J 135 1998 268 271
32. M Dalby, A Bouzamondo, P Lechat, G Montalescot Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis Circulation 108 2003 1809 1814
33. Boersma E, for the The Primary Coronary Angioplasty Versus Thrombolysis (PCAT)-2 Trialists' Collaborative Group. Does time matter? A pooled analysis of randomised clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J (in press).
34. P Widimsky, L Groch, M Zelizko Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory Eur Heart J 21 2000 823 831
35. A Halkin, CL Grines, DA Cox Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction J Am Coll Cardiol 43 2004 1780 1787